Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.10.1.1 extracted from

  • Sidhu, N.S.; Schreiber, K.; Proepper, K.; Becker, S.; Uson, I.; Sheldrick, G.M.; Gaertner, J.; Kraetzner, R.; Steinfeld, R.
    Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA (2014), Acta Crystallogr. Sect. D, 70, 1321-1335.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
drug development the enzyme is a target for the development of structure-based drug design for the devastating neurodegenerative disorder mucopolysaccharidosis type IIIA or Sanfilippo A syndrome Homo sapiens

Cloned(Commentary)

Cloned (Comment) Organism
recombinant expression of C-terminally His6-tagged full-length enzyme in HEK-293 cells Homo sapiens

Crystallization (Commentary)

Crystallization (Comment) Organism
purified recombinant C-terminally His6-tagged, glycosylated full-length enzyme, small unit and large unit crystal forms, X-ray diffraction structure determination and analysis at 2.0-2.4 A resolution, molecular replacement. The enzyme appears to exist as a homodimer in both crystal forms Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
phosphate
-
Homo sapiens
sulfate
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P51688
-
-

Posttranslational Modification

Posttranslational Modification Comment Organism
glycoprotein Asn41, Asn151, Asn264 and Asn413 are four of the five N-glycosylation sites Homo sapiens

Purification (Commentary)

Purification (Comment) Organism
recombinant C-terminally His6-tagged full-length enzyme from HEK-293 cells by nickel affinity croomatography Homo sapiens

Reaction

Reaction Comment Organism Reaction ID
N-sulfo-D-glucosamine + H2O = D-glucosamine + sulfate catalytic reaction mechanism: the active-site formylglycine (FGly70), which is intrinsically reactive, undergoes hydration to form the resting state of the enzyme with a gem-diol group (step 1). Coordination of one of the hydroxyl groups of the gem-diol to a Ca2+ ion facilitates the development of a negative charge on the O atom as its proton is lost to a base. The negatively charged O atom nucleophilically attacks the sulfur centre of the N-linked sulfate group on the glucosamine substrate (step 2), resulting in a covalently bound enzyme-substrate complex with a pentavalent sulfur transition state. An acid (possibly His181) facilitates the cleavage of the S-N bond by protonating the bridging N atom to form an amine leaving group on the N-desulfated substrate, which diffuses away, leaving an O-sulfated enzyme (step 3). Finally, in a step that underlines the importance of the formylglycine residue, another base (His125) deprotonates the second hydroxyl group, resulting in a negatively charged O atom (step 4) that forms a double bond with the C atom as the C-O bond between it and the bridging O atom of the sulfate group breaks, eliminating the sulfate ion and regenerating the formylglycine residue (step 5) Homo sapiens

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
4-methylumbelliferyl-alpha-D-N-sulfoglucosaminide + H2O
-
Homo sapiens 4-methylumbelliferyl alpha-D-glucosaminide + sulfate
-
?
additional information the enzymatic activity of the enzyme is measured in a two-step reaction: 4-methylumbelliferyl-alpha-D-N-sulfoglucosaminide is desulfated by the enzyme to become a substrate for alpha-glucosidase, which converts 4-methylumbelliferyl-alpha-D-N-sulfoglucosamine to methylumbelliferone, which is a fluorescent compound Homo sapiens ?
-
?

Subunits

Subunits Comment Organism
homodimer recombinant enzyme, crystal structure analysis. Two SGSH monomers associate noncovalently to form a butterfly-shaped homodimer burying approximately 10.3% of the accessible surface area of each subunit Homo sapiens
More the monomeric enzyme subunit comprises of two domains, each centred on a beta-sheet: a large N-terminal domain (domain 1) and a smaller C-terminal domain (domain 2), as is typical for the sulfatase fold. There are 14 beta-strands, 13 alpha-helices and six 310-helices (T1-T6) in total Homo sapiens

Synonyms

Synonyms Comment Organism
SGSH
-
Homo sapiens
sulfamate sulfohydrolase
-
Homo sapiens
sulfamidase
-
Homo sapiens

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
37
-
assay at Homo sapiens

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
6.7
-
assay at Homo sapiens

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
1
-
pH 6.7, 37°C, recombinant enzyme Homo sapiens phosphate
5
-
pH 6.7, 37°C, recombinant enzyme Homo sapiens sulfate

General Information

General Information Comment Organism
evolution despite the low sequence identity between the unique N-sulfatase and the group of O-sulfatases, they share a similar overall fold and active-site architecture, including a catalytic formylglycine, a divalent metal-binding site and a sulfate-binding site. A highly conserved lysine in O-sulfatases is replaced in the N-sulfoglucosamine sulfohydrolase by an arginine (Arg282) that is positioned to bind the N-linked sulfate substrate Homo sapiens
malfunction mucopolysaccharidoses are a group of recessively inherited lysosomal storage disorders caused by a deficiency of enzymes involved in the metabolic breakdown of glycosaminoglycans. Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome), a fatal childhood-onset neurodegenerative disease with mild facial, visceral and skeletal abnormalities, is caused by an inherited deficiency of the enzyme N-sulfoglucosamine sulfohydrolase, more than 100 mutations in the SGSH gene are found to reduce or eliminate its enzymatic activity. The Sanfilippo syndrome signs of neurodegeneration are the initial symptoms and comprise of hyperactivity, developmental stagnation and psychomotor regression Homo sapiens
additional information the enzyme shows low structural flexibility. The consensus active site lies in domain 1 in a narrow pocket at the bottom of a surface cleft and close to the end of the first beta-strand, active site structure, overview. Proposed interactions between the terminal N-sulfoglucosamine residue of the substrate with the enzyme in the active site Homo sapiens